Abstract: Cervical cancer is the fourth most common cancer among women worldwide and is the main burden of gynaecologic cancer. Cases of cervical cancer in developing countries account for 85% of the global total, the situation is grim. In recent years, there continue to be improvements in its therapeutic method and treatment effectiveness. However, treatment-related effects, including urinary, gastrointestinal, sexual, lymphedema and psychological side effects, can disrupt long-term quality of life (QoL) in survivors. Factors influencing the above adverse outcomes mainly include treatment methods, surgical procedures and human factors. Factors that affect the poor prognosis include therapeutic method, surgical operation and cultural factors, etc. Methods improving QoL mainly include pharmacological treatment and surgical therapy. Certainly, improving therapeutic method and surgical procedures seems to be more important. Meanwhile, gaining support from family and society is helpful for the survivor.

Key words: Uterine cervical neoplasms, Quality of life, Antineoplastic protocols, Antineoplastic combined chemotherapy protocols